# Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia

> **NCT06036797** · PHASE2 · UNKNOWN · sponsor: **Maternal and Child Health Hospital of Hubei Province** · enrollment: 240 (estimated)

## Conditions studied

- Analgesia
- Labor Pain

## Interventions

- **DRUG:** Hydromorphone
- **DRUG:** Sufentanil
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT06036797
- **Lead sponsor:** Maternal and Child Health Hospital of Hubei Province
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-17
- **Primary completion:** 2023-10-17
- **Final completion:** 2023-10-17
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036797, "Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06036797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*